For specific groups, there probably is a kind of access problem. As for how big it is and the best way to solve this kind of problem—whether is it specifically related to access to pharmaceuticals or a more general problem—I would say that it's a political question. The reforms that I mentioned earlier when it comes to children, and young women when it comes to contraceptives, is one kind of response by the political system in adjusting the thresholds.
On May 2nd, 2017. See this statement in context.